Patents by Inventor Brian Dale Nelson
Brian Dale Nelson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11974775Abstract: Medical devices for accessing the central nervous system, as well as making and using medical devices, are disclosed. An example medical device may include an expandable access port. The expandable access port may include a housing having a plurality of tines coupled thereto. A thrust washer may be disposed along the housing. An actuation member may be coupled to the housing. The actuation member may be designed to shift the plurality of tines between a first configuration and an expanded configuration.Type: GrantFiled: January 22, 2021Date of Patent: May 7, 2024Assignee: MINNETRONIX NEURO, INC.Inventors: Brian Dale Nelson, Don William Eldon Evans
-
Publication number: 20230310025Abstract: Medical devices for accessing the central nervous system, as well as making and using medical devices, are disclosed. An example medical device may include an expandable access sheath having a proximal end region and a distal end region. The expandable access sheath may be designed to shift between a first configuration and an expanded configuration. The expandable access sheath may include a tubular body having one or more axial support members disposed along the tubular body. The medical device may include an expansion member designed to shift the expandable access sheath between the first configuration and the expanded configuration.Type: ApplicationFiled: June 9, 2023Publication date: October 5, 2023Applicant: MINNETRONIX NEURO, INC.Inventors: COREY DANIEL BROWN, DON WILLIAM ELDON EVANS, PHILIP JON HAARSTAD, BRIAN DALE NELSON
-
Patent number: 11707294Abstract: Medical devices for accessing the central nervous system, as well as making and using medical devices, are disclosed. An example medical device may include an expandable access sheath having a proximal end region and a distal end region. The expandable access sheath may be designed to shift between a first configuration and an expanded configuration. The expandable access sheath may include a tubular body having one or more axial support members disposed along the tubular body. The medical device may include an expansion member designed to shift the expandable access sheath between the first configuration and the expanded configuration.Type: GrantFiled: February 15, 2019Date of Patent: July 25, 2023Assignee: MINNETRONIX NEURO, INC.Inventors: Corey Daniel Brown, Don William Eldon Evans, Philip Jon Haarstad, Brian Dale Nelson
-
Publication number: 20210220011Abstract: Medical devices for accessing the central nervous system, as well as making and using medical devices, are disclosed. An example medical device may include an expandable access port. The expandable access port may include a housing having a plurality of tines coupled thereto. A thrust washer may be disposed along the housing. An actuation member may be coupled to the housing. The actuation member may be designed to shift the plurality of tines between a first configuration and an expanded configuration.Type: ApplicationFiled: January 22, 2021Publication date: July 22, 2021Applicant: MINNETRONIX NEURO, INC.Inventors: BRIAN DALE NELSON, DON WILLIAM ELDON EVANS
-
Publication number: 20190247087Abstract: Medical devices for accessing the central nervous system, as well as making and using medical devices, are disclosed. An example medical device may include an expandable access sheath having a proximal end region and a distal end region. The expandable access sheath may be designed to shift between a first configuration and an expanded configuration. The expandable access sheath may include a tubular body having one or more axial support members disposed along the tubular body. The medical device may include an expansion member designed to shift the expandable access sheath between the first configuration and the expanded configuration.Type: ApplicationFiled: February 15, 2019Publication date: August 15, 2019Applicant: MINNETRONIX NEURO, INC.Inventors: COREY DANIEL BROWN, DON WILLIAM ELDON EVANS, PHILIP JON HAARSTAD, BRIAN DALE NELSON
-
Publication number: 20170368433Abstract: A one or two player ball game assembly comprising a motorized ball launcher that shoots balls upwards into the air in a random fountain like pattern. Each player catches or retrieves the launched balls and places them back into their designated reservoir. The reservoir gravity feeds the balls back into a striker mechanism. In one embodiment, the reservoirs are clear tubes so that each player may monitor the number of balls in each player's reservoir during play. The clear tubes also act as a fence, keeping each player on their respective sides thus minimizing possible collisions during play. In one embodiment, the game operates on an adjustable timer (e.g. 1-15 minutes) which automatically terminates powered to the motorized striker. The timer may also trigger an audible signal (e.g. bell) when the game is over. The winner is the player with the most balls in their reservoir at the end of play.Type: ApplicationFiled: June 27, 2016Publication date: December 28, 2017Inventor: Brian Dale Nelson
-
Patent number: 9623969Abstract: An unmanned aerial vehicle (UAV) that can operate both as a conventional multicopter with no wing attached, or, it can operate as a winged multicopter. The detachable wing design used in the invention provides versatility without compromising performance; the wing attachment receptacles add no weight to the wingless multicopter configuration because they also function as the leg receptacles. In one embodiment, the base multicopter configuration is a quad-copter with four propeller drives. Four tubular receptacles, two forward and two aft, provide attachment points for the vertical struts of a detachable rectangular shaped wing, these vertical struts also function as the legs of the multicopter. The wing is fabricated using lightweight struts and rip stop nylon fabric which can be easily folded into a compact shape using quick release pins. In another embodiment, the wing is fabricated using a foam core.Type: GrantFiled: January 17, 2015Date of Patent: April 18, 2017Inventor: Brian Dale Nelson
-
Publication number: 20160272316Abstract: An unmanned aerial vehicle (UAV) that can operate both as a conventional multicopter with no wing attached, or, it can operate as a winged multicopter. The detachable wing design used in the invention provides versatility without compromising performance; the wing attachment receptacles add no weight to the wingless multicopter configuration because they also function as the leg receptacles. In one embodiment, the base multicopter configuration is a quad-copter with four propeller drives. Four tubular receptacles, two forward and two aft, provide attachment points for the vertical struts of a detachable rectangular shaped wing, these vertical struts also function as the legs of the multicopter. The wing is fabricated using lightweight struts and rip stop nylon fabric which can be easily folded into a compact shape using quick release pins. In another embodiment, the wing is fabricated using a foam core.Type: ApplicationFiled: January 17, 2015Publication date: September 22, 2016Inventor: Brian Dale Nelson
-
Patent number: 9272784Abstract: An unmanned aerial vehicle (UAV) comprising a plurality of propeller drives rigidly mounted to a foldable frame with the motor rotors aligned in a vertical direction to provide a means of vertical takeoffs and landings. The foldable frame mounts a sheet sail at an angle with the horizontal that provides lift during the forward motion and tilt of the UAV. In one embodiment the shape of the sheet sail and frame are triangular with one or two propeller drives being mounted in close proximity to each of the three vertices. In another embodiment, the shape of the sheet sail and frame are triangular with one or two propeller drives being mounted in close proximity to each of the three vertices, and one or two propeller drives being mount in close proximity to the trailing edge of the spine, in between the trailing edge propeller drives. In some embodiments, the frame spars may be comprised of carbon fiber rods and the sheet sail may be comprised of ripstop nylon fabric.Type: GrantFiled: May 19, 2014Date of Patent: March 1, 2016Inventor: Brian Dale Nelson
-
Publication number: 20150329204Abstract: An unmanned aerial vehicle (UAV) comprising a plurality of propeller drives rigidly mounted to a foldable frame with the motor rotors aligned in a vertical direction to provide a means of vertical takeoffs and landings. The foldable frame mounts a sheet sail at an angle with the horizontal that provides lift during the forward motion and tilt of the UAV. In one embodiment the shape of the sheet sail and frame are triangular with one or two propeller drives being mounted in close proximity to each of the three vertices. In another embodiment, the shape of the sheet sail and frame are triangular with one or two propeller drives being mounted in close proximity to each of the three vertices, and one or two propeller drives being mount in close proximity to the trailing edge of the spine, in between the trailing edge propeller drives. In some embodiments, the frame spars may be comprised of carbon fiber rods and the sheet sail may be comprised of ripstop nylon fabric.Type: ApplicationFiled: May 19, 2014Publication date: November 19, 2015Inventor: Brian Dale Nelson
-
Publication number: 20150224213Abstract: This invention provides treatment compositions as well as systems and methods of determining and administering an effective amount of treatment for a neurological disorder. The treatment composition can contain a labeled interfering RNA (iRNA) agent capable of decreasing expression of a target RNA associated with the neurological disorder. The methods of the invention include determining an effective amount of a therapeutic composition by introducing a solution containing a tracer into the brain of a mammal. The tracing solution is monitored until a target volume of distribution at steady state distribution is substantially achieved, and the rate of delivery of the therapeutic composition is determined. The therapeutic composition can then be administered at the rate determined by use of the tracing solution.Type: ApplicationFiled: February 12, 2015Publication date: August 13, 2015Inventors: Dinah W.Y. SAH, Andrei P. Guzaev, Matthew H. Adams, Pei Ge, Muthiah Manoharan, Douglas Ulen Gwost, Gregory Robert Stewart, David Kent Stiles, Brian Dale Nelson, William Frederick Kaemmerer, Don Marshall Gash
-
Patent number: 8957038Abstract: This invention provides treatment compositions as well as systems and methods of determining and administering an effective amount of treatment for a neurological disorder. The treatment composition can contain a labeled interfering RNA (iRNA) agent capable of decreasing expression of a target RNA associated with the neurological disorder. The methods of the invention include determining an effective amount of a therapeutic composition by introducing a solution containing a tracer into the brain of a mammal. The tracing solution is monitored until a target volume of distribution at steady state distribution is substantially achieved, and the rate of delivery of the therapeutic composition is determined. The therapeutic composition can then be administered at the rate determined by use of the tracing solution.Type: GrantFiled: July 15, 2010Date of Patent: February 17, 2015Assignee: Medtronic, Inc.Inventors: Dinah W. Y. Sah, Andrei P. Guzaev, Matthew H. Adams, Pei Ge, Muthiah Manoharan, Douglas Ulen Gwost, Gregory Robert Stewart, David Kent Stiles, Brian Dale Nelson, William Frederick Kaemmerer, Don Marshall Gash
-
Publication number: 20120116360Abstract: This invention provides treatment compositions as well as systems and methods of determining and administering an effective amount of treatment for a neurological disorder. The treatment composition can contain a labeled interfering RNA (iRNA) agent capable of decreasing expression of a target RNA associated with the neurological disorder. The methods of the invention include determining an effective amount of a therapeutic composition by introducing a solution containing a tracer into the brain of a mammal. The tracing solution is monitored until a target volume of distribution at steady state distribution is substantially achieved, and the rate of delivery of the therapeutic composition is determined. The therapeutic composition can then be administered at the rate determined by use of the tracing solution.Type: ApplicationFiled: July 15, 2010Publication date: May 10, 2012Applicants: Alnylam Pharmaceuticals, Inc., Medtronic, Inc.Inventors: Dinah W. Y. Sah, Andrei P. Guzaev, Matthew H. Adams, Pei Ge, Muthiah Manoharan, Douglas Ulen Gwost, Gregory Robert Stewart, David Kent Stiles, Brian Dale Nelson, William Frederick Kaemmerer, Don Marshall Gash